Related Experiment Video
Updated: Jun 12, 2026

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection
Published on: May 17, 2024
[Three-year observation of permanent neonatal diabetes]
Anna Noczyńska1, Agnieszka Zubkiewicz-Kucharska, Barbara Salmonowicz
1Katedra i Klinika Endokrynologii i Diabetologii Wsieku Rozwojowego Akademii Medycznej, Wroclaw. anocz@endo.am.wroc.pl
Insights
This study observed children with neonatal diabetes due to KCNJ11 and ABCC8 gene mutations. Sulfonylurea treatment effectively managed blood sugar, though dose reductions were needed.
Area of Science:
- Pediatric Endocrinology
- Molecular Genetics
Background:
- Neonatal diabetes mellitus (NDM) is a rare condition often caused by genetic mutations.
- Permanent NDM can result from activating mutations in KCNJ11 (Kir6.2) and ABCC8 (SUR1) genes.
Observation:
- A three-year follow-up of four children with permanent NDM due to heterozygous KCNJ11/ABCC8 mutations.
- Three patients experienced developmental delay alongside their diabetes.
- Glucagon tests indicated normal c-peptide secretion in all participants.
Findings:
- Treatment with sulfonylureas (SU) maintained glycemic control (HbA1c <7%) in all patients.
- All children required a reduction in their SU dosage over the observation period.
Implications:
- KCNJ11 and ABCC8 mutations are significant causes of permanent neonatal diabetes.
- Sulfonylureas are an effective treatment for this NDM subtype.
- Long-term management may necessitate SU dose adjustments and monitoring for developmental outcomes.
Abstract:
The aim of this paper is to present a three-year observation of four children with permanent neonatal diabetes caused by heterozygous activating mutations in both KCNJ11 gene for Kir6.2 and ABCC8 gene for SUR1 subunits (three patients after three years of clinical observation and one patient after two years of clinical observation, respectively). In three cases with Kir6.2 mutation, developmental delay was diagnosed. In all four patients the glucagon test revealed normal c-peptide secretion. During the treatment with sulfonylureas (SU), glycaemia remained within the normal range, HbA1c<7%, in our patients. In all children reduction a of SU doses was required.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational
Type I Diabetes III: Clinical Manifestations
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes Mellitus: Introduction
Type I Diabetes I: Introduction
